Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis

Guardado en:
Detalles Bibliográficos
Autores principales: Zhong Li, Tao Yang, Xinyu Yang, Lizheng Hao, Changyong Luo, Guomi Wang, Caroline Lin Cai, Shuo Qi
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
R
Acceso en línea:https://doaj.org/article/79c9ebd47ec84a4d8ae803b62800a073
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:79c9ebd47ec84a4d8ae803b62800a073
record_format dspace
spelling oai:doaj.org-article:79c9ebd47ec84a4d8ae803b62800a0732021-11-04T04:00:08ZPrognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis10.1136/bmjopen-2021-0491232044-6055https://doaj.org/article/79c9ebd47ec84a4d8ae803b62800a0732021-09-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/9/e049123.fullhttps://doaj.org/toc/2044-6055Zhong LiTao YangXinyu YangLizheng HaoChangyong LuoGuomi WangCaroline Lin CaiShuo QiBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Zhong Li
Tao Yang
Xinyu Yang
Lizheng Hao
Changyong Luo
Guomi Wang
Caroline Lin Cai
Shuo Qi
Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
format article
author Zhong Li
Tao Yang
Xinyu Yang
Lizheng Hao
Changyong Luo
Guomi Wang
Caroline Lin Cai
Shuo Qi
author_facet Zhong Li
Tao Yang
Xinyu Yang
Lizheng Hao
Changyong Luo
Guomi Wang
Caroline Lin Cai
Shuo Qi
author_sort Zhong Li
title Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
title_short Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
title_full Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
title_fullStr Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
title_full_unstemmed Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
title_sort prognostic value of derived neutrophil-to-lymphocyte ratio (dnlr) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/79c9ebd47ec84a4d8ae803b62800a073
work_keys_str_mv AT zhongli prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT taoyang prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT xinyuyang prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT lizhenghao prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT changyongluo prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT guomiwang prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT carolinelincai prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
AT shuoqi prognosticvalueofderivedneutrophiltolymphocyteratiodnlrinpatientswithnonsmallcelllungcancerreceivingimmunecheckpointinhibitorsametaanalysis
_version_ 1718445338686128128